Tarsus Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-21.1M | $-21.6M | $456.0K | $839.0K |
| FY2021 | $3.7M | $3.2M | $586.0K | $8.5M |
| FY2022 | $-49.0M | $-49.5M | $506.0K | $13.5M |
| FY2023 | $-117.5M | $-119.0M | $1.5M | $19.8M |
| FY2024 | $-83.0M | $-84.6M | $1.6M | $27.8M |